A pancreatic metastasis of anaplastic thyroid carcinoma: a rare case report.
anaplastic thyroid carcinoma
case report
pancreatic metastases
pancreaticoduodenectomy
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
10
10
2022
accepted:
24
12
2022
entrez:
27
2
2023
pubmed:
28
2
2023
medline:
28
2
2023
Statut:
epublish
Résumé
Anaplastic thyroid carcinoma (ATC) is a rare malignancy with a poor prognosis. It is characterized by abrupt development with local and distant metastases. Metastases are essentially present in the lung. Pancreatic metastasis is extremely rare. The authors report that, to their knowledge, this is the first reported case of a patient who developed metachronous pancreatic metastasis related to ATC. A 65-year-old woman, with a history of thyroidectomy, 2 years prior, for an anaplastic thyroid tumor presented in his regular follow-up computed tomography scan a hypodense lesion of the head of the pancreas. Definite diagnosis of neoplasm was difficult following the computed tomography-guided fine-needle aspiration biopsy. The patient had a cephalic duodenopanceatectomy with an uneventful recovery. Histopathology concluded in a pancreatic metastasis of ATC metastasis. The patient had uneventful outcomes with a follow-up of 3 months without tumor recurrence. Pancreatic metastases of thyroid carcinomas are extremely rare, particularly for ATC. The diagnosis of metastases is based on a regular follow-up. The prognosis is poor despite curative surgery.
Identifiants
pubmed: 36845795
doi: 10.1097/MS9.0000000000000179
pmc: PMC9949859
doi:
Types de publication
Journal Article
Langues
eng
Pagination
228-230Informations de copyright
© 2023 the Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no financial conflict of interest with regard to the content of this report.
Références
Cancer. 1997 Feb 1;79(3):564-73
pubmed: 9028369
Int J Surg Case Rep. 2022 Sep;98:107581
pubmed: 36057252
Curr Opin Oncol. 2003 Jan;15(1):78-83
pubmed: 12490766
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2277-85
pubmed: 20694463
Arch Pathol Lab Med. 2015 Oct;139(10):1248-52
pubmed: 26414469
Clin Nucl Med. 2021 Apr 1;46(4):337-339
pubmed: 33492854
Surgery. 2001 Dec;130(6):1028-34
pubmed: 11742333
Thyroid. 2013 Jun;23(6):709-13
pubmed: 23148580
Cancer Epidemiol. 2018 Apr;53:65-71
pubmed: 29414634
Ann Med Surg (Lond). 2022 Aug 19;81:104460
pubmed: 36147158
Thyroid. 2020 Oct;30(10):1505-1517
pubmed: 32284020
Int J Surg. 2020 Dec;84:226-230
pubmed: 33181358
J Endocrinol Invest. 2008 Nov;31(11):1032-7
pubmed: 19169062
Thyroid. 2012 Nov;22(11):1104-39
pubmed: 23130564
Langenbecks Arch Surg. 2005 Jun;390(3):203-8
pubmed: 15599758
Adv Anat Pathol. 2018 May;25(3):172-179
pubmed: 29351089
J Gastrointest Cancer. 2019 Mar;50(1):9-15
pubmed: 30618003
Diagn Cytopathol. 2019 Mar;47(3):214-217
pubmed: 30479026
Thyroid. 2021 Mar;31(3):337-386
pubmed: 33728999